Navigation Links
Research shows single-patient rooms reduce hospital infections in ICU
Date:1/11/2011

This release is available in French.

Montreal, January 10, 2011 A research team from the McGill University Health Centre (MUHC) and McGill University has demonstrated that private rooms in the Intensive Care Unit (ICU) play a key role in reducing hospital infections like C-difficile. The study, published today in the journal Archives of Internal Medicine, also suggests that length of stay would be shorter and this could lead to cost savings to the healthcare system.

Infection control in hospitals is a worldwide health concern that can have a serious impact on patient morbidity, mortality and the cost of treatment particularly in the ICU, where patients are highly susceptible to infection. Single-patient rooms have long been considered to provide patients with better protection from hospital infections. However, previous studies investigating this issue have been inconclusive. "We had a valuable opportunity to examine the rates of acquisition of infection in patients during a change from multi-bed to single rooms in the ICU at the MUHC," explains Dana Teltsch, lead author of the study and Ph.D. candidate in the Dept. of Epidemiology, Biostatistics and Occupational Health at McGill.

The results show that the infection acquisition rate after room privatization fell about 50 percent for three bacteria of most concern Staphylococcus aureus (MRSA), C-difficile and Enterococcus (VRE). "We also observed a 10 percent reduction in the length of stay in the ICU after changing to private rooms. These findings provide a basis of comparison of the savings versus the costs to the healthcare system on top of the health benefits to patients," said Teltsch. It is estimated each case of C. difficile can cost of up to $7000 per episode.

"This study is the first evaluation of the full range of the benefits of private rooms in an ICU environment and highlights the important role that physical infrastructure plays in the prevention of transmission of healthcare associated pathogens," said Dr. Vivian Loo, one the co-author's of the study, Chief of Microbiology at the MUHC and Associate Professor in McGill's Department of Medicine. "Of course, other factors are also important in preventing transmission, like hand hygiene, isolation precautions, antibiotic stewardship and housekeeping practices, but this study clearly demonstrates the crucial need for private rooms, particularly for this patient population."

"Private rooms can help our patients avoid infections and also aid the healthcare system as a whole in decreasing length of stay associated with hospital-acquired infections," says Dr. David Buckeridge, senior author, Associate Professor in the Dept. of Epidemiology, Biostatistics and Occupational Health at McGill and a Medical Scientist in the Department of Medicine at the Research Institute of the MUHC. "We did not measure all of the costs and benefits of private rooms in our study, but they are an investment that, once built, should continue to provide substantial benefit."

All rooms at the New MUHC, at the Glen, Lachine and Mountain campuses, will be single-patient rooms where natural light, a comfortable family area, and a private bathroom will contribute to the healing of both body and mind. Apart from limiting the spread of infections, single-patient rooms ensure privacy and confidentiality, give patients a sense of control and provide enough space for medical equipment to be wheeled in beside beds, meaning that patients can stay in their rooms for routine exams, treatments or tests.


'/>"/>

Contact: Julie Robert
julie.robert@muhc.mcgill.ca
514-843-1560
McGill University Health Centre
Source:Eurekalert

Related biology news :

1. AAAS honors Iowa State, Ames Lab researchers for distinguished science
2. New research aims to shut down viral assembly line
3. Researchers brave icy waters to study Arctic food web
4. Carnegie Mellon researchers identify Facebook neurons
5. Symposium to provide forum for best pre-clinical and translational bone research
6. Researchers create scoring system for PTEN mutation testing
7. Researchers show how Alzheimers plaques lead to loss of nitric oxide in brain
8. Research identifies drug target for prion diseases, mad cow
9. Mayo researchers describe measles viral protein movement
10. Increasing diversity of future life science researchers
11. Biofuel grasslands better for birds than ethanol staple corn, researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... SAN FRANCISCO and WARSAW, Poland , Nov. 30, 2016 ... sleeping. It is one of the most crucial aspects of recovery so we need ... host of serious health risks, including heart problems, high blood pressure, stroke, diabetes, and ... family and friends sleep and find a Christmas present that could help them to ... ...
(Date:11/29/2016)... Lithuania , Nov. 29, 2016 /PRNewswire/ ... biometric identification and object recognition technologies, today ... (SDK) for fingerprint recognition solutions that run ... a fingerprint template using less than 128KB ... in compact devices that have limited on-board ...
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... ... 05, 2016 , ... This composition patent, U.S. Patent No. ... The composition claims are not limited to any particular process to make or ... carbon fibers, graphene, and other materials. A continuation application, U.S. Patent App. ...
(Date:12/5/2016)... , Dec. 5, 2016  Renova™ Therapeutics, ... congestive heart failure and other chronic diseases, announced ... the company as Chief Financial Officer (CFO), effective ... with 20 years of experience in financial management ... biotech and software companies. Most recently, Ms. Bovenizer ...
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
(Date:12/2/2016)... ... ... In anticipation of AxioMed’s exclusive cleanroom manufacturing facility in ... Lubinski will be traveling to Switzerland from December 5-10. Mr. Lubinski will meet ... to discuss the benefits of a viscoelastic disc. AxioMed received CE mark in ...
Breaking Biology Technology: